July 2018 Fitness Summary

Another month has passed and what a month it has been! I’ve been enjoying my life and good weather for sure. Doing sports was part of the fun and I wasn’t lagging behind. I managed to participate in two triathlon races, broke my Olympic distance record again but let’s start from the beginning. These wereRead More

July 2018 Summary

One more month is behind us. We only have one month of summer left this year but it has been a great one! I don’t remember having so many hot days during Lithuanian summer. It already feels that it’s too much heat but I guess we will miss it when winter comes. Another month behindRead More

July 2018 Watchlist

Once again, I am almost ready to do my next purchase, so it’s time to look around and see what market has to offer. It’s always a pleasure to look for another “brick” to go into my small dividend house 🙂 This is the third time when I am creating such a watchlist and IRead More

June 2018 Summary

The first month of summer is behind us! It was a great month in general – we had a week-long vacation, I was consistently training for triathlon, the weather was good most of the time. I wish I could say the same for my dividend income. After a stellar May, June was quite slow, asRead More

May 2018 Fitness Summary

We are approaching the end of June and I am quite late with my fitness review for the month of May. Well, as they say, it’s better late than never, so I decided to remember what happened in previous month and record it in this post. These are some highlights from the month of May:Read More

May 2018 Summary

Another month is over and what a month it has been! I don’t remember such a nice May in terms of weather here in Lithuania. It feels like summer for a month already, even though officially it just started. To make the month even better, my portfolio generated a record dividend income, as my annualRead More

Recent Buy – Pfizer (PFE)

I shared a watchlist of stocks that caught my attention recently. After some thinking and discussion with my wife, I decided that Pfizer is looking the most attractive at the moment. Perhaps it’s not the best thing to say but I don’t think that people will stop buying medicine in the nearest future. Healthcare/drug manufacturingRead More